BACK TO CONTENTS
GLOBAL NEWS
Mozzie manipulation Researchers at CSIRO's Australian Animal Health Laboratory may have found a solution to curtail the spread of dengue virus (DENV) by genetically engineering mosquitoes to reduce their vector competence, thereby restricting their capability to acquire and transmit pathogens. The findings offer a proof-of-concept of the capability of genome engineering and the reduction of arboviruses. The genome-engineered mosquitoes, Aedes aegypti, are reported to be 100% resistant to the four DENV serotypes – a world first. Although the lab-based findings are compelling, the journey from the laboratory to the real-world has just begun for the modified mosquitoes, as a genetic drive mechanism will need to be demonstrated to ensure future generations of mosquitoes continue to supress DENV serotypes.
Human cooling The mean human body temperature has decreased in the United States since the industrial revolution according to researchers at the Stanford University School of Medicine. In 1868, the mean body temperature of 37°C was established as by German physician Carl Reinhold August Wunderlich. The researchers analysed three population datasets ranging from 1862 to 1930, 1971 to 1975 and 2007 to 2017, which featured 677,423 temperature measurements According to the researchers, the human body temperature decreasing at -0.03°C per birth decade for men and -0.029°C for women. Men of today were reported to have -0.59°C body temperature decrease as compared to men born in the early 19th century, while women of today were reported to be -0.32°C cooler. The authors suggest the body temperature changes could be causal to a decrease in metabolic rate, which is hypothesised to a population-level reduction in inflammation since the 19th century.
Billions slashed Johnson & Johnson Pharmaceutical will be breathing a little easier after an appeal for a review of an $8 billion damages verdict was upheld and reduced to $6.8 million.
12 | FEBRUARY 2020
The New York Times reports that a Philadelphian judge slashed the jury verdict over the marketing of the antipsychotic drug Risperdal, manufactured by J&J subsidiary Janssen. In October the jury found the company had played down the drug’s risks, which could lead to breast growth in boys. The lawsuit was filed by a Maryland man, Nicholas Murray, who sued the company in 2013 after he suffered gynecomastia after he began using Risperdal in 2003, at age nine, to treat symptoms of autism.
Bugs alive! The WHO has called on governments to intervene in the pharmaceutical industry’s inertia when it comes to R & D of new antimicrobials. It estimates that without government help, resistant infections could kill 10 million people a year by 2050. Apart from the human suffering that would have a severe impact of the global economy. But it’s not all bad news from the UN agency. In its report on potential innovative therapies, the WHO identified 252 agents in development that target 12 pathogens declared ‘grave threats to humanity’ including multidrugresistant E. coli, salmonella and the bacteria that cause gonorrhea. On the other hand, WHO reports that only eight new antibiotics have been approved since 2017, most
of which are derivatives of existing drugs. Of the 50 new antibiotics being tested in clinical trials, only two are active against the most worrisome class of bugs, called gram negative bacteria, that can prove deadly for newborns, cancer patients and those undergoing elective procedures such as hip and knee replacements.
AI accuracy Further evidence supporting clinical efficacy of artificial intelligence (AI) systems has been published in the journal Nature. Researchers from Imperial College London, Deep Mind and Google Health designed the study to compare the accuracy of mammogram interpretations between six radiologists and an AI system. The radiologists and the algorithm were presented with anonymised and randomised imaging datasets from the UK and USA. Findings from the study demonstrate the effectiveness of AI systems when compared to highly trained, specialised humans with the AI outperforming the doctors with reductions of false positives reported as 5.7% and 1.2% (USA and UK data) and false negatives 9.4% and 2.7%.
continued on Page 14
MEDICAL FORUM | INNOVATION & TRENDS ISSUE
